| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vyne Therapeutics Inc. (VYNE) has 8 insiders with recent SEC Form 4 filings, including 7 buys and 3 sells. VYNE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 416.2K | $275.9K | - | |
| Other | 125.9K | $83.5K | - | |
| Other | 115.2K | $76.4K | - | |
| CFO | 103.8K | $68.8K | - | |
| Dir | 20.0K | $13.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Lepore Patrick G | Director | Buy | 15,000 | $2.92 | $43,800.00 | +41.1% | -34.1% | -79.5% | |
| Nov 15, 2023 | Lepore Patrick G | Director | Buy | 13,000 | $3.91 | $50,778.00 | +55.4% | -51.2% | -31.1% | |
| Mar 20, 2023 | Harsch Mutya | Chief Legal Officer And GC | Buy | 10,000 | $2.50 | $25,000.00 | +78.6% | +96.5% | -18.0% | |
| Mar 20, 2023 | Lepore Patrick G | Director | Buy | 20,000 | $2.48 | $49,680.00 | +576.0% | +96.5% | -18.0% | |
| Nov 30, 2021 | Lepore Patrick G | Director | Buy | 12,500 | $1.02 | $12,698.75 | +25.0% | -47.4% | -77.4% | |
| Aug 25, 2021 | Lepore Patrick G | Director | Buy | 12,500 | $1.60 | $20,000.00 | +33.3% | -36.7% | -79.3% | |
| Aug 16, 2021 | Perceptive Advisors LLC51 | 10% Owner | Sell | 250,000 | $1.74 | $435,000.00 | -4.8% | -28.1% | -80.7% | |
| Aug 13, 2021 | Perceptive Advisors LLC51 | 10% Owner | Sell | 250,000 | $1.84 | $460,000.00 | -4.6% | -24.7% | -82.3% | |
| Aug 12, 2021 | Perceptive Advisors LLC51 | 10% Owner | Sell | 338,897 | $2.23 | $755,740.31 | -5.9% | -34.2% | -84.1% | |
| May 26, 2021 | Lepore Patrick G | Director | Buy | 12,500 | $3.60 | $44,957.50 | +50.0% | -56.2% | -89.4% |